search
Back to results

Study on the Treatment of Degenerative Lumbar Spine Stenosis With a Percutaneous Interspinous Implant

Primary Purpose

Lumbar Spinal Stenosis

Status
Terminated
Phase
Phase 4
Locations
Germany
Study Type
Interventional
Intervention
Spacer
physiotherapy
Sponsored by
University of Cologne
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Lumbar Spinal Stenosis focused on measuring PIDLSS, Spacer

Eligibility Criteria

50 Years - 99 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Male or female over 50 years of age
  2. One, two, or three segment degenerative lumbar spinal stenosis (DLSS)
  3. Symptoms of radiographically confirmed DLSS like leg, buttock, or groin pain with or without back pain and absence of a peripheral motoric deficit
  4. Pain relief in inclination or sitting
  5. Ability to walk over a distance of 50 m
  6. Unsuccessful conservative therapy for 3 months under outpatient conditions
  7. Informed consent

Exclusion Criteria:

  1. Fixed motoric deficit
  2. Cauda equina syndrome
  3. Previous surgery of the lumbar spine
  4. Severe osteoporosis of the vertebrae and/or of the hip
  5. Spondylolisthesis more severe than Meyerding I (on scale of I-IV)
  6. Metastasis of the vertebrae
  7. Mentally disabled persons

Sites / Locations

  • University Hospital Cologne
  • University Hospital of Cologne

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Other

Arm Label

Spacer

physiotherapy

Arm Description

Implantation of a percutaneously implanted interspinous device ("spacer")

The control group will receive at least physiotherapy and physical therapy (e.g. massage and fango). Under inpatient conditions therapy will last for seven days. After discharge physical therapy has to be continued for 5 weeks. A schedule will ensure the consistency of the physical therapy. The inpatient-treatment can be repeated every 6 months if necessary.

Outcomes

Primary Outcome Measures

Changes in subscores for bodily pain and physical function on SF-36

Secondary Outcome Measures

Symptoms severity by applying the Zurich Claudication Questionaire (ZCQ)
Physical function by applying ZCQ
Post-treatment patient satisfaction by applying ZCQ
General health status (Quality of life) by applying SF-36
Measurement of walking distance

Full Information

First Posted
January 26, 2010
Last Updated
November 4, 2016
Sponsor
University of Cologne
search

1. Study Identification

Unique Protocol Identification Number
NCT01057641
Brief Title
Study on the Treatment of Degenerative Lumbar Spine Stenosis With a Percutaneous Interspinous Implant
Official Title
A Clinical Study on the Treatment of Degenerative Lumbar Spine Stenosis With a Percutaneous Interspinous Implant in Comparison With the Best Non-operative Treatment of Lumbar Spine Stenosis
Study Type
Interventional

2. Study Status

Record Verification Date
November 2016
Overall Recruitment Status
Terminated
Why Stopped
low enrollment
Study Start Date
March 2011 (undefined)
Primary Completion Date
May 2016 (Actual)
Study Completion Date
June 2018 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Cologne

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Neurogenic intermittent claudication is a specific symptom complex occurring in patients with lumbar spinal stenosis. Characteristic of this disease is the occurrence of increasing leg, buttock or groin pain with or without lower back pain when walking a certain distance or reclining. Bending forward or sitting leads to a rapid pain relief. Lumbar spinal stenosis is defined as a reduction of the diameter of the spinal canal. The mechanism leading to stenosis is a remodeling and overgrowth of the spinal canal with osteophyte formation. Any loss of tissue or decrease of the disc height results in a relative laxity of the ligament structures and accelerates the degeneration of the spinal joints. As a therapy option, conservative therapy with oral analgesics and physical therapy is considered. This treatment can be intensified by adding epidural pain treatment. Is the conservative treatment not successful surgical intervention is necessary. In patients over 65 years of age operative decompression of the lumbar spinal stenosis constitutes the most common surgical operation of the spine. A relatively new therapy alternative is the interspinous process decompression (IPD). Studies have shown that the IPDs prevent narrowing of the spinal canal and neural foramens. The study is intended as a randomised, monocentre study to investigate the safety and the benefit of a minimally invasive percutaneous IPD-device in comparison with the best non-surgical operative treatment of lumbar spinal stenosis.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Lumbar Spinal Stenosis
Keywords
PIDLSS, Spacer

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
22 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Spacer
Arm Type
Experimental
Arm Description
Implantation of a percutaneously implanted interspinous device ("spacer")
Arm Title
physiotherapy
Arm Type
Other
Arm Description
The control group will receive at least physiotherapy and physical therapy (e.g. massage and fango). Under inpatient conditions therapy will last for seven days. After discharge physical therapy has to be continued for 5 weeks. A schedule will ensure the consistency of the physical therapy. The inpatient-treatment can be repeated every 6 months if necessary.
Intervention Type
Procedure
Intervention Name(s)
Spacer
Other Intervention Name(s)
PIDLSS
Intervention Description
Implantation of a percutaneously implanted interspinous device (spacer)
Intervention Type
Other
Intervention Name(s)
physiotherapy
Other Intervention Name(s)
PIDLSS
Intervention Description
physiotherapy
Primary Outcome Measure Information:
Title
Changes in subscores for bodily pain and physical function on SF-36
Time Frame
baseline, 6 months
Secondary Outcome Measure Information:
Title
Symptoms severity by applying the Zurich Claudication Questionaire (ZCQ)
Time Frame
baseline, 6 months
Title
Physical function by applying ZCQ
Time Frame
baseline, 6 months
Title
Post-treatment patient satisfaction by applying ZCQ
Time Frame
baseline, 6 months
Title
General health status (Quality of life) by applying SF-36
Time Frame
baseline, 6 months
Title
Measurement of walking distance
Time Frame
baseline, 6 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
50 Years
Maximum Age & Unit of Time
99 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Male or female over 50 years of age One, two, or three segment degenerative lumbar spinal stenosis (DLSS) Symptoms of radiographically confirmed DLSS like leg, buttock, or groin pain with or without back pain and absence of a peripheral motoric deficit Pain relief in inclination or sitting Ability to walk over a distance of 50 m Unsuccessful conservative therapy for 3 months under outpatient conditions Informed consent Exclusion Criteria: Fixed motoric deficit Cauda equina syndrome Previous surgery of the lumbar spine Severe osteoporosis of the vertebrae and/or of the hip Spondylolisthesis more severe than Meyerding I (on scale of I-IV) Metastasis of the vertebrae Mentally disabled persons
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Thomas Kaulhausen, MD
Organizational Affiliation
University Hospital of Cologne
Official's Role
Principal Investigator
Facility Information:
Facility Name
University Hospital Cologne
City
Cologne
State/Province
NRW
ZIP/Postal Code
50931
Country
Germany
Facility Name
University Hospital of Cologne
City
Cologne
ZIP/Postal Code
50924
Country
Germany

12. IPD Sharing Statement

Learn more about this trial

Study on the Treatment of Degenerative Lumbar Spine Stenosis With a Percutaneous Interspinous Implant

We'll reach out to this number within 24 hrs